BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8207996)

  • 1. [Chronic eosinophilic pneumonia in a patient treated with allogenic bone marrow transplantation].
    Richard C; Calavia J; Loyola I; Baró J; Cuadrado MA; Gómez-Casares MT; Zurbano F; Ondiviela R; Zubizarreta A
    Med Clin (Barc); 1994 Apr; 102(12):462-4. PubMed ID: 8207996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic eosinophilic pneumonia involving eosinophil cationic protein and bone marrow cells].
    Nakamura Y; Hoshino M; Miyasaka T; Shimizu K; Yamashiro Y; Joon J; Sim ; Hosaka K; Uchida K; Fukushima Y; Akasaka Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Oct; 34(10):1115-20. PubMed ID: 8953906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic eosinophilic pneumonia: a case report.
    Phunmanee A; Boonsawat W; Charoensiri DJ; Limkunacul C
    J Med Assoc Thai; 2000 Aug; 83(8):959-63. PubMed ID: 10998853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
    Ota K; Hashino S; Shimizu K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Imamura M; Asaka M
    Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread pulmonary fibrosis as a major clinical manifestation of chronic graft-versus-host disease.
    Atkinson K; Bryant D; Delprado W; Biggs J
    Bone Marrow Transplant; 1989 Jan; 4(1):129-32. PubMed ID: 2647179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
    Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal eosinophilic disease following autologous bone marrow transplantation.
    Gross TG; Hoge FJ; Jackson JD; Sammut PH; Warkentin PI
    Bone Marrow Transplant; 1994 Aug; 14(2):333-7. PubMed ID: 7994253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rapid onset of hemolytic anemia after allogeneic bone marrow transplantation from an unrelated ABO major mismatched donor].
    Watanabe H; Asai O; Tada N; Yano S; Katoh A; Katori M; Kobayashi T; Kuraishi Y; Hoshi Y; Itoh K; Aizawa S
    Rinsho Ketsueki; 1997 Jan; 38(1):14-20. PubMed ID: 9028156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunological syndrome featuring transverse myelitis, Evans syndrome and pulmonary infiltrates after unrelated bone marrow transplant in a patient with severe aplastic anemia.
    Richard S; Fruchtman S; Scigliano E; Skerrett D; Najfeld V; Isola L
    Bone Marrow Transplant; 2000 Dec; 26(11):1225-8. PubMed ID: 11149736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute myelogenous leukemia with mediastinal and subcutaneous emphysema following chronic GVHD after allogeneic bone marrow transplantation].
    Doki N; Irisawa H; Saito Y; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2005 Sep; 46(9):1038-43. PubMed ID: 16440761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eosinophilic pneumonia causing severe respiratory insufficiency. Clinical case].
    Arrese M; Castellón JM; Contreras G
    Rev Med Chil; 1991 Mar; 119(3):299-302. PubMed ID: 1842125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Idiopathic interstitial pneumonitis possibly associated with chronic graft-versus-host disease].
    Gondo H; Harada M; Hara N; Harada N; Asou N; Hayashi S; Akashi K; Niho Y; Minematsu T; Minamishima Y
    Rinsho Ketsueki; 1993 Feb; 34(2):183-9. PubMed ID: 8492416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation for sickle cell disease. The United States experience.
    Johnson FL; Mentzer WC; Kalinyak KA; Sullivan KM; Abboud MR
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):22-6. PubMed ID: 8311168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.
    Hernández-Boluda JC; Marín P; Carreras E; Aguilar JL; Grañena A; Rozman C; Montserrat E
    Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperkalemia in a cyclosporine A-treated allogeneic bone marrow transplant recipient].
    Kinugawa N; Okimoto Y; Ota S
    Rinsho Ketsueki; 1992 Jan; 33(1):53-7. PubMed ID: 1545516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure.
    Mehta J; Powles R; Singhal S; Matthey F; Hamblin M; Middleton G; Prendiville J; Glynne P; Zomas A; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 May; 17(5):881-3. PubMed ID: 8733715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
    Atkinson K; Downs K
    Bone Marrow Transplant; 1995 Dec; 16(6):755-8. PubMed ID: 8750265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.